Biocryst Pharmaceuticals Inc (BCRX)

Finanzdaten der Biocryst Pharmaceuticals Inc-Aktie (BCRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	39.53%218.25	156.41	406.56	159.40	163.35
Cost Of Revenue	28.58%3.84	5.38	9.52	2.19	2.80
	32.34%63.98	94.55	-	-	-
Selling, General, and Administrative	32.34%63.98	94.55	-	-	-
Research and Development	13.84%51.97	60.32	-	-	-
Costs And Expenses	86.04%119.79	858.01	146.17	129.80	133.57
Operating Income/Loss	114.03%98.47	-701.60	260.39	29.59	29.79
Nonoperating Income/Loss	1.14%-18.99	-19.21	-12.37	-17.46	-23.30
Income/Loss From Continuing Operations Before Tax	111.03%79.47	-720.81	248.02	12.13	6.49
Income Tax Expense/Benefit	7.47%1.08	1.00	2.17	-0.77	1.40
	110.86%78.40	-721.81	245.85	12.90	5.09
Attributable To Parent	110.86%78.40	-721.81	245.85	12.90	5.09
Basic Average Shares	5.05%254.48	242.26	0.36	210.18	209.52
Diluted Average Shares	9.46%265.17	242.26	0.23	219.89	219.89
Basic Earnings Per Share	110.40%0.31	-2.98	1.17	0.06	0.02
Diluted Earnings Per Share	110.07%0.30	-2.98	1.13	0.06	0.02